Did You Take Zofran for Morning Sickness?
Did You Take Zofran During Your First Trimester?
Was Your Baby Born With Cleft Palate
or a Congenital Heart Defect?
CALL TODAY: (877) 978-0169

Blog

New Zofran (Ondansetron) Label Draws Ire of Families in MDL

Families involved in the Zofran (ondansetron) multidistrict litigation (“MDL”) alleged a 2016 label update for Zofran acknowledged for the first time that studies have shown an increased link between exposure to Zofran (ondansetron) and cardiovascular and cleft palate birth defects in babies born to women who took the drug while pregnant. However, the families contend …. Read More

Comments Off on New Zofran (Ondansetron) Label Draws Ire of Families in MDL

No Trials, but Many Tribulations Over Zofran (ondansetron): Drug Safety System Putting Children In-Utero at Risk

Alabama mother Marquita Smiley began taking the generic form of anti-nausea drug Zofran (ondansetron) regularly during her first trimester to treat debilitating morning sickness—but when her son Zaidan was born with a critically underdeveloped heart, necessitating open heart surgery at just 3 days old, Marquita started to wonder whether the drug she took might have been …. Read More

Comments Off on No Trials, but Many Tribulations Over Zofran (ondansetron): Drug Safety System Putting Children In-Utero at Risk

Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

At the April 2016 Mass Torts Made Perfect conference in Las Vegas later this month, Grant & Eisenhofer Director Elizabeth Graham, co-lead on the Plaintiffs’ Executive Committee of the Zofran (ondansetron) multi-district litigation, will speak to the latest developments in the litigation. Ms. Graham will cover the status of the over 230 cases centralized before …. Read More

Comments Off on Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL

In March 2016, with more than 200 lawsuits pending in the Zofran (ondansetron) federal multi-district litigation (“MDL”) in the District of Massachusetts, plaintiffs submitted their proposal on the sequence and effect of “Master Pleadings.” In a sequence of master pleadings, usually created for administrative reasons, master complaints collate claims brought in each case into a single …. Read More

Comments Off on Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL

Louisiana Family Files Zofran (ondansetron) Lawsuit over Heart Defects

In one of the latest complaints filed against GlaxoSmithKline LLC over the anti-nausea drug Zofran (ondansetron), a family from Louisiana claims that the drug caused their two children to be born with heart defects. Zofran (ondansetron) was first approved by the FDA in 1991 for use in cancer patients undergoing chemotherapy or radiation therapy and …. Read More

Comments Off on Louisiana Family Files Zofran (ondansetron) Lawsuit over Heart Defects
Contact Us
Web Analytics